Janux Therapeutics, Inc.
JANX
$23.70
$0.472.02%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 54.11% | 55.60% | 197.99% | 88.16% | 113.09% |
Total Receivables | -52.80% | 26.79% | 149.01% | 162.00% | 703.73% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 7.27% | 44.44% | 1.97% | 1.40% | -20.45% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 51.91% | 55.37% | 195.97% | 87.59% | 114.01% |
|
|||||
Total Current Assets | 51.91% | 55.37% | 195.97% | 87.59% | 114.01% |
Net Property, Plant & Equipment | -11.02% | -11.69% | -13.26% | -12.15% | -10.13% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.53% | 8.02% | 11.28% | 16.26% | 6.37% |
Total Assets | 49.29% | 52.51% | 179.05% | 79.66% | 102.46% |
|
|||||
Total Accounts Payable | 177.49% | 4.30% | 66.09% | -1.72% | -34.40% |
Total Accrued Expenses | 87.08% | 129.60% | 58.17% | 90.63% | -7.03% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 14.91% | 15.13% | 15.29% | 15.53% | 15.77% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -98.25% |
Total Other Current Liabilities | -- | -- | -- | -- | -98.25% |
Total Current Liabilities | 85.18% | 64.97% | 33.96% | 18.67% | -35.52% |
|
|||||
Total Current Liabilities | 85.18% | 64.97% | 33.96% | 18.67% | -35.52% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -8.44% | -8.01% | -7.60% | -7.21% | -6.84% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 23.60% | 15.30% | 7.42% | 2.67% | -19.74% |
|
|||||
Common Stock & APIC | 51.03% | 51.22% | 145.56% | 70.73% | 90.32% |
Retained Earnings | -55.75% | -42.36% | -40.88% | -38.56% | -30.28% |
Treasury Stock & Other | 331.87% | 816.79% | 225.26% | 766.47% | -52.45% |
Total Common Equity | 50.61% | 54.40% | 197.02% | 88.02% | 119.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 50.61% | 54.40% | 197.02% | 88.02% | 119.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 50.61% | 54.40% | 197.02% | 88.02% | 119.61% |
|